Home » Topics » BioWorld Science

BioWorld Science
RSS

Transgene opens enrollment in phase I study of TG-4050 for ovarian cancer

Dec. 12, 2019

Xintela's function-blocking antibody suppresses growth of glioblastoma tumors in preclinical model

Dec. 12, 2019

Canadian researchers synthesize new androgen receptor antagonists

Dec. 12, 2019

Helix begins phase Ib/II study of L-DOS47 in previously treated pancreatic cancer

Dec. 12, 2019

Roche and Genentech identify SCN9A blockers

Dec. 12, 2019

3M Pharmaceuticals presents cytokine-releasing compounds for infections

Dec. 12, 2019

Beijing Scitech-Mq Pharmaceuticals patents EGFR and/or ALK inhibitors

Dec. 12, 2019

BAR Pharmaceuticals describes new NR1H4 antagonists

Dec. 12, 2019

Transgene and BioInvent report preclinical data on BT-001 for solid tumors

Dec. 12, 2019

Positive early phase I data for Genmab's CD3xCD20 bispecific antibody GEN-3013

Dec. 12, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...